Abbott logo

A REPORT FROM THE ECONOMIST INTELLIGENCE unit

IMPROVING CANCER RISK ASSESSMENT AND PROGNOSIS: THE ROLE OF MAAAS

OPPORTUNITIES FOR CANCER RISK ASSESSMENT AND PROGNOSIS

Improving cancer risk assessment and prognosis: the role of Multianalyte Assays with Algorithmic Analyses provides insights on Multianalyte Assays with Algorithmic Analysis (MAAAs), which are tests that combine two or more biomarkers into an algorithm to generate a disease risk assessment or prognostic result. These tests potentially offer better performance than single biomarker.

ANALYZING CURRENT PRACTICES

MAAAs have been adopted for use in Eastern Countries such as China, but to this point, Western Countries, particularly European and North American countries, have not embraced these algorithms. We explore the use of these algorithms in areas where they have been incorporated into screening and testing protocols and discuss potential reasons why there has been less uptake for use in other places.

COMPLETE THE FORM TO DOWNLOAD THE REPORT

* Required Fields

Subscribe to receive news and resources from Abbott
I consent to Abbott's collection, use, and/or processing of my personal information. Abbott is committed to keeping your information confidential. We will not sell, rent, or lease your personal information. *

CORE LABORATORY |  DIAGNOSTICS |  PRIVACY POLICY |  TERMS AND CONDITIONS


© 2022 Abbott, Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product and service names appearing in this internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the products or services of the company.


ADD-139134-GBL-EN